Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05925426 · ClinicalTrials.gov registry record
Defining The Quality Of Intraoperatively Salvaged Blood For Deformity Surgery
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 103
- Enrollment target
NCT05925426: Completed study, sponsored by NYU Langone Health.
NCT05925426 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 103 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05925426 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 103 participants
- Enrollment target
Study Summary
The actual quality of Red Blood Cells (RBCs) salvaged during spinal deformity surgery has never been rigorously evaluated. To characterize the usefulness of intraoperatively salvaged RBCs in spinal deformity surgery. The study team hopes to answer the following questions: 1) What is the quality of RBCs salvaged during spine surgery? 2) Does intraoperatively transfused RBC salvage impact clinical outcomes?
Primary Outcome
LDH assays will be performed following a standardized mechanical stress test will be used to determine whether salvaged red blood cells exhibit signs of fragility ex vivo.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2023-09-30 |
What the finished NCT05925426 record still lists
NCT05925426 is an observational study that tracks outcomes without assigning an intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05925426 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05925426 about?
NCT05925426 is a clinical study titled "Defining The Quality Of Intraoperatively Salvaged Blood For Deformity Surgery". The actual quality of Red Blood Cells (RBCs) salvaged during spinal deformity surgery has never been rigorously evaluated. To characterize the usefulness of intraoperatively salvaged RBCs in spinal deformity surgery. The study team hopes to answer the following questions: 1) What is the quality of R...
What is the current status of trial NCT05925426?
This trial is currently completed. The enrollment target is 103 participants. The study started on 2022-07-01. Estimated completion is 2023-09-30.
Who is sponsoring clinical trial NCT05925426?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI